ondansetron has been researched along with Central Nervous System Diseases in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tralongo, P | 1 |
| Dimari, A | 1 |
| Conti, G | 1 |
| Aiello, R | 1 |
| Mauceri, G | 1 |
1 other study available for ondansetron and Central Nervous System Diseases
| Article | Year |
|---|---|
Central nervous system side-effects of 5-HT3-receptor antagonists in elderly cancer patients treated with chemotherapy.
Topics: Aged; Antineoplastic Agents; Central Nervous System Diseases; Clinical Trials as Topic; Granisetron; | 2004 |